Renibus Therapeutics Funding: $72M Raised, Series A (2022)
Renibus Therapeutics is based in Southlake, Texas. It has raised $72M in total funding. Latest round: Series A.
Renibus Therapeutics funding overview
Renibus Therapeutics is based in Southlake, Texas. Renibus Therapeutics has raised $72M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in February 2022. The round record for Renibus Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include family offices specializing in biotech investments.
Renibus Therapeutics at a glance
Total raised
$72M
Latest round
Series A
Latest round date
February 2022
Headquarters
Southlake, Texas
Notable investors
family offices specializing in biotech investments
Frequently asked about Renibus Therapeutics funding
How much has Renibus Therapeutics raised?
Renibus Therapeutics has raised $72M in total disclosed funding across the rounds on record.
Who has invested in Renibus Therapeutics?
family offices specializing in biotech investments are named among the investors backing Renibus Therapeutics.
What was the latest Renibus Therapeutics funding round?
The most recent disclosed round is a Series A, announced in February 2022.
Where is Renibus Therapeutics based?
Renibus Therapeutics is based in Southlake, Texas.
When did Renibus Therapeutics last raise?
The last disclosed Renibus Therapeutics round closed in February 2022 at Series A.
Round data for Renibus Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Southlake and backer lists below.
